New drugs being developed for neurosteroidogenesis (aside from SAGE-217)

Hi, I just found this. Seems further down the line than even Zuranolone though.

GRX-917:

https://finance.yahoo.com/news/gaba-therapeutics-atai-life-sciences-130000937.html

From a cursory look, it’s etifoxine with a better safety profile and lower/less frequent dosing.

Perhaps this means we’re witnessing a new trend in psychiatry as neurosteroids may be the next gold rush for big pharma?

1 Like

And another one, in the form of a spray for MDD.

PH-10:

https://seekingalpha.com/article/4302533-vistagen-therapeutics-ph10s-approval-potential-just-outweigh-stock-dilution-risk

Hoping that we’re about to arrive at a watershed in psychiatry. Also VTGN chart seems to have bottomed out. What is stock dilution though? Seems like a good entry if you’re a gambler.